RESUMEN
ObjectiveTo investigate the effect of Qizil guliqent on gastrointestinal hormone in normal rats.MethodsThe rats in experimental groups were administered with Qizil guliqent(4g/kg,6g/kg,8g/kg ),madinglin (0.0027g/kg),and the rats in normal control group were given 0.5％ CMC-Na for twenty days.The method ELISA was used to detect the content of gastric motility(MTL),vasoactive intestinal peptide(VIP) and Gastrin(GAS) in serum of normal rats.ResultsIn comparison with normal control group,VIP increased in Qizil guliqent group(4g/kg,6g/kg) (P ＜0.05 ～P ＜ 0.01 );but MTL,GAS were not significantly changed in this group( P ＞ 0.05 ).MTL,GAS were increased in Qizil guliqent group ( 8g/kg ) and madinglin group (0.0027g/kg) ( P ＜ 0.05 ) ; but VIP was not significantiy changed in this group(P ＞ 0.05 ).ConclusionQizil guliqent could regulate gastrointestinal hormones in rats,and dose related.
RESUMEN
<p><b>OBJECTIVE</b>To investigate the acute toxicity, lipid reducing effect and mechanism of action of ethanol extracts of Matbuhi Aftimun (E-MA), a classic prescription of Uighur medicine, on hyperlipidemia rat model.</p><p><b>METHODS</b>The LD50 or maximum tolerance of rats to E-MA was determined by simplified probit method. Hyperlipidemia rat model was established in SD rats by feeding high lipid emulsion, then E-MA at different dosages (0.80 g/kg, 1.60 g/kg and 3.20 g/kg) was given orally to them. The effects of E-MA on model rats' serum lipids, including total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), triglyceride (TG), were observed. And its effects on malondialdehydec (MDA) content, superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), total lipase, including lipoprotein lipase (LPL) and hepato-lipase (HL) activities in the liver homogenate were assayed.</p><p><b>RESULTS</b>The maximum tolerance of rats to E-MA was 64 g (crude drug)/kg. Compared with the hyperlipidemia model rat, the blood TC level was lower (P < 0.05 or P < 0.01), and the MDA content in the liver homogenate was higher in model rat after E-MA treatment (at all the three specified dosages, P < 0.01), but no significant difference was found in comparisons of serum levels of LDL-C, HDL-C and TG (P > 0.05), also on the levels of SOD, GSH-PX and total lipase in the liver homogenate (P > 0.05).</p><p><b>CONCLUSION</b>E-MA shows a serum TC reducing effect on hyperlipidemia rat model with low toxicity in mice.</p>
